Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
Clinical trial NCT00300950 · COMPLETED
Trial details
- NCT number
- NCT00300950
- Sponsor
- GlobeImmune
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.